Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer
Non-Small-Cell Lung Cancer (NSCLC), Brain Metastasis
About this trial
This is an interventional treatment trial for Non-Small-Cell Lung Cancer (NSCLC) focused on measuring Neurobehavioral Assessments, Neurocognitive Functions (NCF), Prophylactic Cranial Irradiation (PCI), Hippocampus, Hippocampal-Sparing PCI
Eligibility Criteria
Inclusion Criteria:
- Clinical diagnosis of NSCLC
- Must be adult patients (≥ 18 years old) who have received definitive surgery and have a permanent pathology of nodal metastasis
- Platinum-based chemotherapy is mandatory
- Good performance status better than Eastern Cooperative Group (ECOG) of 2 or a general status of Karnofsky (KPS) > 70 %
- Should have sufficient proficiency in Mandarin language
Exclusion Criteria:
- Have received prior cranial irradiation
- Presence of other active primary cancer (exception of basal cell carcinoma of skin and cervical carcinoma in situ)
- Radiographic evidence of brain metastasis/metastases
- Clinical evidence of extracranial metastatic disease
- Hypersensitivity to magnetic resonance (MR) contrast enhancer
- Serious medical or psychiatric illness
Sites / Locations
- Chang Gung Memorial HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
PCI via hippocampal-sparing WBRT
observation without PCI
All studied patients should undergo a computed tomography (CT) simulation scan encompassing the entire head region with 1.25-mm slice thickness using a thermoplastic mask for immobilization. To achieve conformal hippocampal sparing during the delivery of WBRT, the technique of volumetric modulated arc therapy (VMAT) via Linac-based RapidArc® or TrueBeamTM is employed in our treatment planning. All treatment plans are delivered by using the Linac Varian-iX or TrueBeamTM. In terms of dose prescription, a dose of 30 Gy in 15 fractions is prescribed to whole-brain planning target volume (PTV) under the setting of prophylactic cranial irradiation for NSCLC patients.